Becker's Healthcare May 16, 2025
Erica Carbajal

The White House has launched a new program focused on leveraging technology and private sector partnerships to find new ways to quickly produce key pharmaceutical ingredients and finished drugs at the point-of-care.

The initiative, called Equip-A-Pharma, involves collaborations with Mark Cuban’s Cost Plus Drugs and three other healthcare partners.

Five details:

  1. The effort aims to strengthen the nation’s drug supply chain by enabling quicker approval times for drugs produced using novel manufacturing technologies, lowering production costs, reducing shortages and improving rapid response to national emergencies, officials said in a May 15 news release.
  2. The program includes partnerships with four private health companies: Cost Plus Drugs; Battelle Memorial Institute and Aprecia; Bright Path; and New Brunswick, N.J.-based...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Congress / White House, Govt Agencies, Partnerships, Pharma, Pharma / Biotech, Trends
Navigating the Shift: 2026 Medicare Drug Pricing and the Future of Pharmacy
Podcast: Medicaid vs. 340B: A Drug Pricing Clash (Sayeh Nikpay)
Q&A: New PQA Resource Highlights 40 Projects Targeting Social Determinants of Health
NVIDIA and Lilly Announce Co-Innovation AI Lab to Accelerate Drug Discovery
The Future of Pharmacovigilance Technology: How AI and Automation Are Redefining Drug Safety

Share Article